# Aime vs Evalify

Aime records 260,428 monthly visits with +11.4% month-over-month growth and Freemium pricing. Evalify records 496 monthly visits with +48.1% growth and Contact for Pricing pricing.

| Metric | [Aime](https://openaitools.app/tool/aime) | [Evalify](https://openaitools.app/tool/evalify) |
| :--- | :--- | :--- |
| Website URL | https://www.ainvest.com | https://www.evalify.ai |
| Categories | AI Investing, AI News, AI Stock Trading, AI For Finance | AI Investing, AI Legal Assistant, AI Research Tool |
| Pricing Model | Freemium | Contact for Pricing |
| Monthly Visits | 260,428 | 496 |
| MoM Growth Rate | +11.4% | +48.1% |
| Primary Market | United States | Global |
| Direct Visits | 116,185 | 198 |
| Review Score | 4.2 | 4.2 |
| Saved Count | 6 | 1 |
| Supported Platforms | Website | Website |

## Aime

Aime lives inside AInvest, a platform that combines market data, financial news and generative AI into a research workspace. Instead of jumping between screeners, filings and news feeds, you ask Aime a question in natural language — about a company's business model, its latest earnings, how it stacks up on valuation, or what moved the price recently — and it returns an organized answer you can then verify against primary sources.

The tool is deliberately framed as a research aid rather than a signal generator. AInvest pairs Aime with an AI stock screener for narrowing a market universe, charting tools at chart.ainvest.com, ETF comparison pages and portfolio-analysis explanations. The platform also publishes guides on AI stock analysis, AI stock predictions and backtesting, and is explicit that predictions cannot guarantee a future price or return and should be treated as inputs to question, not buy or sell signals.

AInvest offers free access to core research features with paid Aime tiers for heavier usage, and it promotes a downloadable AInvest Terminal desktop app that unlocks free credits. It is a general-purpose market research workspace aimed at self-directed investors rather than an execution or brokerage product.

**Pricing & Plans:** Freemium. AInvest offers free access to core research and Aime features, with additional paid Aime plans for expanded usage. A desktop terminal app is offered with free credits. Check the official pricing page for current tiers.

- **Conversational stock research:** Ask Aime about a company's business, financial results, valuation, price activity or recent news and get an organized, source-oriented answer.
- **AI stock screener:** Narrow a broad market universe down to candidates that match your research criteria, then dig into individual results.
- **Charts and ETF comparison:** Interactive charting plus side-by-side ETF comparison views to research funds and relative performance.
- **Portfolio analysis guidance:** Explore questions about diversification, concentration and allocation using Aime alongside the platform's research tools.
- **Market news and signals feed:** Real-time market data, financial news and signal summaries that give Aime's answers current context.

**Strengths:** Combines market data, news and generative AI in one research workspace; Natural-language questions are far faster than manual screening for initial orientation; Free tier makes core research features accessible without commitment; Covers stocks, ETFs, charts and portfolio concepts rather than a single data point

**Limitations:** Direct page loads use a JavaScript bot check, so scripted access can be blocked; AI answers still need verification against primary sources before acting; Prediction and analysis features come with significant uncertainty by nature

[Profile (Markdown)](https://openaitools.app/tool/aime.md)

## Evalify

Evalify targets the most labor-intensive part of patent practice: the search. Rather than handing back thousands of raw documents, it designs a search strategy with you, executes it across 200M+ patents and 170+ jurisdictions, then drafts a first-pass freedom-to-operate opinion with every flagged claim charted limitation by limitation. Multiple AI agents cross-examine the charts and explicitly surface where they disagree, so the attorney can see the uncertainty instead of a falsely tidy answer.

Each run returns two deliverables: a short FTO Brief covering the opinion, the Score, clearance by jurisdiction and the critical patents, plus a long Full Report documenting every charted claim, the patents screened out with reasons, and the methodology. Both can be exported as PDF or editable Word, and Counsel-Grade users can compose exports under their own firm's branding.

Confidentiality is treated as a first-class feature. Uploaded inputs — technical disclosures, draft claims, product descriptions — are never retained, the working copy is destroyed after processing, and client material is never used as training data. Analyses and reports stay in the user's own account. Evalify positions its output as a preliminary assessment requiring attorney review, not legal advice.

**Pricing & Plans:** Evalify does not publish a conventional public price list; the site routes prospective users to a pricing conversation and a free first analysis. In its manual-search comparison the company places its own cost per matter below $500, against thousands of dollars for a traditional search. A Standard tier exports the FTO Brief as PDF, while a Counsel-Grade tier unlocks the Export Composer (both documents as PDF or editable Word), monitoring of a matter and enterprise white-labeling. Confirm current figures directly with Evalify.

- **Drafted first-pass FTO opinion:** Produces a reasoned infringement verdict and per-jurisdiction risk framing in the structure attorneys already use, so the deliverable is an editable draft rather than a pile of search results.
- **Element-by-element claim charts:** Every limitation of every charted claim is mapped against the product with the verdict and the reasoning that produced it, making the analysis auditable rather than a black-box score.
- **Evalify Score (250-900):** A single clearance number built from the chart verdicts, designed to be defensible for an attorney and legible to a business client.
- **Multi-agent cross-examination:** Several AI agents review each claim chart and flag disagreements explicitly, so unresolved conflicts are visible and the human decides.
- **Zero-retention confidentiality:** Uploaded inputs are never stored, are wiped after processing, and are never used to train models; only your analyses and reports persist in your account.

**Strengths:** Turns an exhausting manual search into a drafted opinion with claim charts; Explicit zero-retention policy on client input material; Transparent cross-examination of AI charts instead of a single opaque answer; Export to editable Word and firm-branded, white-label output

**Limitations:** No public self-serve price list; cost requires a conversation; Output is explicitly a preliminary assessment and still requires attorney review; Pricing page URL currently returns a 404, so tier details must be confirmed directly

[Profile (Markdown)](https://openaitools.app/tool/evalify.md)

## Frequently Asked Questions

### How do Aime and Evalify compare in monthly traffic?

Aime has 260,428 monthly visits, while Evalify has 496. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Aime has a month-over-month growth rate of +11.4%; Evalify has +48.1%.

### How does pricing compare?

Aime: Freemium. Freemium. AInvest offers free access to core research and Aime features, with additional paid Aime plans for expanded usage. A desktop terminal app is offered with free credits. Check the official pricing page for current tiers. Evalify: Contact for Pricing. Evalify does not publish a conventional public price list; the site routes prospective users to a pricing conversation and a free first analysis. In its manual-search comparison the company places its own cost per matter below $500, against thousands of dollars for a traditional search. A Standard tier exports the FTO Brief as PDF, while a Counsel-Grade tier unlocks the Export Composer (both documents as PDF or editable Word), monitoring of a matter and enterprise white-labeling. Confirm current figures directly with Evalify.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Thomson Reuters](https://openaitools.app/tool/thomson-reuters) | 17,919,413 | +5.5% | Contact for Pricing | Purpose-built AI and trusted content for legal, tax, risk and trade professionals | [.md](https://openaitools.app/tool/thomson-reuters.md) |
| 2 | [Harvey](https://openaitools.app/tool/harvey-ai) | 1,832,998 | +26.1% | Contact for Pricing | Domain-specific AI for law firms, in-house legal teams, and professional services | [.md](https://openaitools.app/tool/harvey-ai.md) |
| 3 | [MacroMicro](https://openaitools.app/tool/macromicro) | 928,258 | +22.5% | Freemium, Paid | Focuses heavily on global macroeconomics and interactive charts paired with an AI assistant, offering broader economic data. | [.md](https://openaitools.app/tool/macromicro.md) |
| 4 | [Patsnap Eureka](https://openaitools.app/tool/patsnap-eureka) | 414,305 | +3.1% | Freemium | Domain-specific AI agents for innovation, R&D, and intellectual property | [.md](https://openaitools.app/tool/patsnap-eureka.md) |
| 5 | [AI Lawyer](https://openaitools.app/tool/ai-lawyer) | 221,106 | +1.5% | Free Trial | Your personal AI legal assistant for research, drafting, and document review | [.md](https://openaitools.app/tool/ai-lawyer.md) |
| 6 | [Danelfin](https://openaitools.app/tool/danelfin-com) | 216,830 | -11.1% | Freemium | Assigns machine learning probability scores to stocks for outperformance, trading conversational chat for quantitative scoring models. | [.md](https://openaitools.app/tool/danelfin-com.md) |
| 7 | [Intellectia.Ai](https://openaitools.app/tool/intellectia-ai) | 171,347 | +18% | Free Trial, Paid | Offers AI-driven stock and ETF analysis similar to Aime, with integrated market research tools and screeners. | [.md](https://openaitools.app/tool/intellectia-ai.md) |
| 8 | [vLex](https://openaitools.app/tool/vlex-com-mx) | 140,457 | +0.7% | Free Trial, Contact for Pricing | Legal AI that understands the law | [.md](https://openaitools.app/tool/vlex-com-mx.md) |
| 9 | [AltIndex](https://openaitools.app/tool/altindex) | 97,418 | -12.6% | Freemium, Free Trial | Alternative-data platform scoring stocks based on web traffic and social buzz instead of general financial chat. | [.md](https://openaitools.app/tool/altindex.md) |
| 10 | [Amsflow](https://openaitools.app/tool/amsflow) | 37,303 | +72.2% | Free Trial, Paid | Features built-in AI assistants for market analysis within an all-in-one charting and investment research platform. | [.md](https://openaitools.app/tool/amsflow.md) |

---
Source: https://openaitools.app/compare/aime-vs-evalify

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)